Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinzaparin Thrombin Generation in Myeloma, Lymphoma, and Acute Medical Patients
NCT02260414Phase 2Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Apr 2015
- Primary completion
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of tinzaparin in venous thromboembolism (VTE), sponsored by CHU Saint-Etienne. Started Apr 2015; status: completed.
02
Drugs
tinzaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02260414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260414.